CHARLOTTE, N.C. (WCBD) – One of the first clinical trials to test a drug treatment for COVID-19 is set to begin in Charlotte.
Novant Health will begin to test a drug created by Cytodyn, Inc.
It will be administered to trial participants by injection twice over a two week period.
This is the second phase of a trial first tested in New York.
The drug, known as Leronlimab, will be tested in COVID-19 patients with mild or moderate symptoms.
The testing locations will be in Charlotte, Salisbury, and Winston-Salem.
“The hypothesis for this clinical trial is that this agent will interfere with that inflammatory process and keep patients from having to go on a ventilator.”Dr. Steven Limentani, Chief Scientific Officer, Novant Health
Another goal of the treatment is to prevent the virus from harming other cells in the body.
The trial will contain a placebo-control to see just how truly effective the new drug could be.
Currently, there are also other experimental agents being tested to fight COVID-19.
Long term, if these clinical trials prove to be effective the drug would then have to be approved by the Food and Drug Administration.